investorscraft@gmail.com

Intrinsic ValueKagome Co., Ltd. (2811.T)

Previous Close¥2,732.00
Intrinsic Value
Upside potential
Previous Close
¥2,732.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Kagome Co., Ltd. operates as a leading player in Japan's packaged foods sector, specializing in condiments, beverages, and health-focused products. The company's diversified portfolio includes soups, supplements, and vegetable-based offerings, leveraging its long-standing expertise in agricultural sourcing and food processing. Kagome maintains a vertically integrated model, controlling production from seed procurement to retail distribution, which enhances quality control and cost efficiency. Its strong brand recognition and heritage since 1899 position it as a trusted name in Japan's consumer defensive market. The company also engages in ancillary businesses like real estate and contract services, providing additional revenue streams. Kagome's focus on health-conscious products aligns with growing consumer demand for functional foods, reinforcing its competitive edge in a mature industry.

Revenue Profitability And Efficiency

Kagome reported revenue of JPY 306.9 billion for FY2024, with net income of JPY 25.0 billion, reflecting a net margin of approximately 8.2%. Operating cash flow stood at JPY 31.7 billion, supported by disciplined cost management. Capital expenditures of JPY 10.9 billion indicate ongoing investments in production capabilities, though free cash flow remains positive, underscoring operational efficiency.

Earnings Power And Capital Efficiency

The company's diluted EPS of JPY 278.19 demonstrates solid earnings power, with a beta of 0.49 suggesting lower volatility relative to the market. Kagome's capital allocation balances reinvestment in core operations with stable profitability, though its debt-to-equity ratio warrants monitoring given total debt of JPY 72.7 billion.

Balance Sheet And Financial Health

Kagome holds JPY 21.3 billion in cash and equivalents against total debt of JPY 72.7 billion, indicating moderate liquidity. The balance sheet reflects a conservative leverage profile typical of consumer defensive firms, with sufficient coverage for near-term obligations. Its real estate holdings may provide additional financial flexibility.

Growth Trends And Dividend Policy

Kagome's growth is driven by premiumization and health-focused product lines, though the mature domestic market limits rapid expansion. The dividend per share of JPY 48 reflects a commitment to shareholder returns, with a payout ratio aligned with industry peers. Future growth may hinge on international expansion or innovation in functional foods.

Valuation And Market Expectations

With a market cap of JPY 268.4 billion, Kagome trades at a P/E multiple reflective of its stable but slow-growth profile. The low beta suggests investor perception of resilience, though premium valuation depends on sustained margin improvement and niche market dominance.

Strategic Advantages And Outlook

Kagome's strengths include brand equity, vertical integration, and a focus on health trends. Challenges include demographic headwinds in Japan and input cost volatility. Strategic initiatives in R&D and supply chain optimization could enhance long-term competitiveness, while diversification into adjacent categories offers growth avenues.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount